靶向IL-12B的高亲和纳米体用于荧光共振能量转移检测。

IF 1.4 4区生物学 Q4 BIOCHEMICAL RESEARCH METHODS

Protein expression and purification Pub Date : 2025-02-05 DOI:10.1016/j.pep.2025.106681

Jing Hu , Wenxuan Feng , Jianchuan Wen , Siyu Zhou , Zengchao Sun , Shuaiying Zhao , Shaojue Guo , Hui Wang , Yong Geng

{"title":"靶向IL-12B的高亲和纳米体用于荧光共振能量转移检测。","authors":"Jing Hu , Wenxuan Feng , Jianchuan Wen , Siyu Zhou , Zengchao Sun , Shuaiying Zhao , Shaojue Guo , Hui Wang , Yong Geng","doi":"10.1016/j.pep.2025.106681","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>IL-12B, a subunit of the IL-23 family of cytokines, plays a crucial role in various diseases such as viral infections, autoimmune disorders, and tumors. This study aimed to identify high-affinity nanobodies that bind to distinct epitopes of IL-12B to and assess their potential for therapeutic and diagnostic applications, particularly through fluorescence resonance energy transfer(FRET) to evaluate their ability to target IL-12B.</div></div><div><h3>Methods</h3><div>IL-12B protein was expressed in eukaryotic cells and used to immunize camels to induce an immune response. Camel-derived anti-IL-12B nanobodies were isolated and screened via phage display to identify those with high specificity and affinity for IL-12B. Binding affinity and epitope interactions were further analyzed using high-performance liquid chromatography (HPLC) and ForteBio Octet assays. A FRET-based assay was developed to evaluate protein interactions for precise therapeutic targeting.</div></div><div><h3>Results</h3><div>Several high-affinity nanobodies targeting IL-12B were successfully generated. These nanobodies exhibited strong binding to various epitopes of IL-12B. Screening by HPLC and ForteBio Octet confirmed their high specificity and affinity, while fluorescence analysis demonstrated efficient energy transfer between thenanobodies, indicating successful interactions.</div></div><div><h3>Conclusions</h3><div>This study identified high-affinity nanobodies against IL-12B and used FRET to characterize their interactions. These nanobodies show promise for therapeutic potential targeting IL-12B-related diseases, including viral infections, autoimmune disorders, and cancer. However, further clinical studies are needed to fully explore their potential for diagnostic and therapeutic applications.</div></div>","PeriodicalId":20757,"journal":{"name":"Protein expression and purification","volume":"229 ","pages":"Article 106681"},"PeriodicalIF":1.4000,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"High-affinity nanobodies targeting IL-12B for the detection of fluorescence resonance energy transfer\",\"authors\":\"Jing Hu , Wenxuan Feng , Jianchuan Wen , Siyu Zhou , Zengchao Sun , Shuaiying Zhao , Shaojue Guo , Hui Wang , Yong Geng\",\"doi\":\"10.1016/j.pep.2025.106681\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aims</h3><div>IL-12B, a subunit of the IL-23 family of cytokines, plays a crucial role in various diseases such as viral infections, autoimmune disorders, and tumors. This study aimed to identify high-affinity nanobodies that bind to distinct epitopes of IL-12B to and assess their potential for therapeutic and diagnostic applications, particularly through fluorescence resonance energy transfer(FRET) to evaluate their ability to target IL-12B.</div></div><div><h3>Methods</h3><div>IL-12B protein was expressed in eukaryotic cells and used to immunize camels to induce an immune response. Camel-derived anti-IL-12B nanobodies were isolated and screened via phage display to identify those with high specificity and affinity for IL-12B. Binding affinity and epitope interactions were further analyzed using high-performance liquid chromatography (HPLC) and ForteBio Octet assays. A FRET-based assay was developed to evaluate protein interactions for precise therapeutic targeting.</div></div><div><h3>Results</h3><div>Several high-affinity nanobodies targeting IL-12B were successfully generated. These nanobodies exhibited strong binding to various epitopes of IL-12B. Screening by HPLC and ForteBio Octet confirmed their high specificity and affinity, while fluorescence analysis demonstrated efficient energy transfer between thenanobodies, indicating successful interactions.</div></div><div><h3>Conclusions</h3><div>This study identified high-affinity nanobodies against IL-12B and used FRET to characterize their interactions. These nanobodies show promise for therapeutic potential targeting IL-12B-related diseases, including viral infections, autoimmune disorders, and cancer. However, further clinical studies are needed to fully explore their potential for diagnostic and therapeutic applications.</div></div>\",\"PeriodicalId\":20757,\"journal\":{\"name\":\"Protein expression and purification\",\"volume\":\"229 \",\"pages\":\"Article 106681\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-02-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Protein expression and purification\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1046592825000233\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOCHEMICAL RESEARCH METHODS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Protein expression and purification","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1046592825000233","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}

引用次数: 0

摘要

目的：IL-12B是IL-23细胞因子家族的一个亚基，在病毒感染、自身免疫性疾病、肿瘤等多种疾病中发挥重要作用。本研究旨在鉴定与IL-12B不同表位结合的高亲和力纳米体，并评估其治疗和诊断应用的潜力，特别是通过荧光共振能量转移（FRET）来评估其靶向IL-12B的能力。方法：在真核细胞中表达IL-12B蛋白，用免疫法诱导骆驼免疫应答。利用噬菌体展示技术对骆驼源性抗IL-12B纳米体进行筛选，鉴定出对IL-12B具有高特异性和亲和力的纳米体。利用高效液相色谱（HPLC）和ForteBio Octet检测进一步分析结合亲和力和表位相互作用。开发了一种基于fret的检测方法来评估蛋白质相互作用，以实现精确的治疗靶向。结果：成功生成了多个靶向IL-12B的高亲和力纳米体。这些纳米体显示出与IL-12B的各种表位的强结合。高效液相色谱和ForteBio Octet筛选证实了它们的高特异性和亲和力，而荧光分析显示纳米体之间有效的能量传递，表明相互作用成功。结论：本研究确定了针对IL-12B的高亲和力纳米体，并利用FRET表征了它们的相互作用。这些纳米体显示出治疗il - 12b相关疾病的潜力，包括病毒感染、自身免疫性疾病和癌症。然而，需要进一步的临床研究来充分挖掘其诊断和治疗应用的潜力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

High-affinity nanobodies targeting IL-12B for the detection of fluorescence resonance energy transfer

查看原文本刊更多论文

High-affinity nanobodies targeting IL-12B for the detection of fluorescence resonance energy transfer

Aims

IL-12B, a subunit of the IL-23 family of cytokines, plays a crucial role in various diseases such as viral infections, autoimmune disorders, and tumors. This study aimed to identify high-affinity nanobodies that bind to distinct epitopes of IL-12B to and assess their potential for therapeutic and diagnostic applications, particularly through fluorescence resonance energy transfer(FRET) to evaluate their ability to target IL-12B.

Methods

IL-12B protein was expressed in eukaryotic cells and used to immunize camels to induce an immune response. Camel-derived anti-IL-12B nanobodies were isolated and screened via phage display to identify those with high specificity and affinity for IL-12B. Binding affinity and epitope interactions were further analyzed using high-performance liquid chromatography (HPLC) and ForteBio Octet assays. A FRET-based assay was developed to evaluate protein interactions for precise therapeutic targeting.

Results

Several high-affinity nanobodies targeting IL-12B were successfully generated. These nanobodies exhibited strong binding to various epitopes of IL-12B. Screening by HPLC and ForteBio Octet confirmed their high specificity and affinity, while fluorescence analysis demonstrated efficient energy transfer between thenanobodies, indicating successful interactions.

Conclusions

This study identified high-affinity nanobodies against IL-12B and used FRET to characterize their interactions. These nanobodies show promise for therapeutic potential targeting IL-12B-related diseases, including viral infections, autoimmune disorders, and cancer. However, further clinical studies are needed to fully explore their potential for diagnostic and therapeutic applications.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Protein expression and purification 生物-生化研究方法

CiteScore

3.70

自引率

6.20%

发文量

120

审稿时长

32 days

期刊介绍： Protein Expression and Purification is an international journal providing a forum for the dissemination of new information on protein expression, extraction, purification, characterization, and/or applications using conventional biochemical and/or modern molecular biological approaches and methods, which are of broad interest to the field. The journal does not typically publish repetitive examples of protein expression and purification involving standard, well-established, methods. However, exceptions might include studies on important and/or difficult to express and/or purify proteins and/or studies that include extensive protein characterization, which provide new, previously unpublished information.